Overview
- 54 inspections across 50 sites are on record.
- 78 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-24.
At a glance
Inspections
54
Sites
50
Observations
78
Career since
Oct 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Anupama Nehra, M.D. | 24 Mar 2025 | Human Drugs | On file |
| Novo Nordisk Inc. | 7 Feb 2025 | Human Drugs | On file |
| Rosa Maria Jimenez Rodriguez, M.D.,Ph.D. | 20 Dec 2024 | Human Drugs | On file |
| Celgene Corporation | 6 Dec 2024 | Human Drugs | On file |
| BRACCO DIAGNOSTICS INC | 27 Nov 2024 | Human Drugs | On file |
Sites inspected
Anupama Nehra, M.D.Newark, United States1 insp.
Novo Nordisk Inc.Plainsboro, United States1 insp.
Rosa Maria Jimenez Rodriguez, M.D.,Ph.D.Sevilla, Spain1 insp.
Celgene CorporationSummit, United States1 insp.
BRACCO DIAGNOSTICS INCPrinceton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Serrano13 shared
Mayar M Mussa3 shared
Jay B Shah2 shared
Shirley S Wen2 shared
Vanessa E Coulter1 shared
Asia D Clark1 shared
Joanne M Schlossin1 shared
Kent A Conforti1 shared
Full investigator report
Get the verbatim findings behind Tyanna N Hadley's 78 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site